Last reviewed · How we verify
NCT05859958
ABO Blood Group Type Association With COVID-19 Severity
trial testing No Intervention in COVID-19 in 599 participants. Completed in 10 May 2023.
10 May 2023
Quick facts
| Lead sponsor | Arrowhead Regional Medical Center |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 599 |
| Start date | 10 November 2022 |
| Primary completion | 10 May 2023 |
| Estimated completion | 10 May 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- No Intervention
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Blood Group Antigen Abnormality — all drugs for Blood Group Antigen Abnormality →
- Blood Group Incompatibilities — all drugs for Blood Group Incompatibilities →
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Arrowhead Regional Medical Center
Who can join
Adults 18 to 90, any sex, with COVID-19 or Blood Group Antigen Abnormality. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The COVID-19 pandemic has caused a significant healthcare burden and remains a heavily researched disease entity. Originating in Wuhan, China in late 2019, SARS-CoV-2 has infected over 600 million individuals worldwide. ABO blood groups have been known to increase the human body's susceptibility to different pathogens, such as hepatitis B virus, MERS-COV, SARS-COV, norovirus, and malaria, to name a few. As such, the association of ABO blood groups and COVID-19 infection and disease severity has come into question.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05859958
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of No Intervention
Trials testing the same drug.
- NCT07353099 — A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma · not yet recruiting
- NCT07429942 — A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Recei · not yet recruiting
- NCT07521917 — Child Abuse and Neglect Awareness Training in Nursing Students · NA · not yet recruiting
- NCT07319832 — A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome · recruiting
- NCT07425574 — A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · recruiting
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other Arrowhead Regional Medical Center trials
Trials by the same sponsor.
- NCT07056062 — Oral Calcium Supplementation in Labor · Phase 2, PHASE3 · completed
- NCT06366698 — Intravenous Iron Versus Oral Iron for the Treatment of Iron Deficiency Anemia · Phase 3 · recruiting
- NCT06543290 — Azithromycin Before Induction · Phase 1 · recruiting
- NCT06402669 — Extremity Trauma At a Level 1 Trauma Center · completed
- NCT05897528 — Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05859958 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Arrowhead Regional Medical Center
- Last refreshed: 26 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05859958.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing